SCHEMBL4447065

SCHEMBL4447065

CC(C)(C)[Si](C)(C)C(Br)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2810741 0.76
SCHEMBL2076291 0.70 TDP1 (0.33)
SCHEMBL17491822 0.67
SCHEMBL20985453 0.67 LMNA (0.35)
SCHEMBL2686579 0.65
SCHEMBL1663096 0.63
SCHEMBL5806133 0.62 PRKCA (0.32)
SCHEMBL7810060 0.62 THRB (0.32)
SCHEMBL16797539 0.60
SCHEMBL9174410 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487533-B2 Phosphoinositide 3-kinase inhibitor compounds and methods of use GENENTECH, INC. (US) 2016-11-08 US disclosed
EP-2114950-B1 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2016-03-09 EP disclosed
EP-2114950-A2 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE Genentech, Inc. (US) 2009-11-11 EP disclosed
US-20080269210-A1 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2008-10-30 US disclosed
WO-2008073785-A2 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2008-06-19 WO disclosed
US-5214139-A 2-phenanthridonyl-carbapenems MERCK & CO., INC. (US) 1993-05-25 US disclosed
US-5208328-A Intermediates for antibiotics and bactericides MERCK & CO., INC. (US) 1993-05-04 US disclosed
EP-0509780-A1 2-phenanthridonyl carbapenems MERCK & CO. INC. (US) 1992-10-21 EP disclosed
EP-0509756-A1 2-Phenanthridonyl carbapenems having cationizeable substituents MERCK & CO. INC. (US) 1992-10-21 EP disclosed
US-5157033-A Controlling methicillin-resistant grampositive Staphylococcus; bactericides MERCK & CO., INC. (US) 1992-10-20 US disclosed
US-5153185-A Antibiotics for methicillin resistant Staphylococcus strains MERCK & CO., INC. (US) 1992-10-06 US disclosed